Cargando…

Safety of hydroxychloroquine in COVID-19 and other diseases: a systematic review and meta-analysis of 53 randomized trials

INTRODUCTION: Many concerns still exist regarding the safety of hydroxychloroquine (HCQ) in the treatment of Coronavirus Disease 2019 (COVID-19). OBJECTIVES: The purpose of this study was to evaluate the safety of HCQ in the treatment of COVID-19 and other diseases by performing a systematic review...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Can, Pan, Kunming, Wu, Bingjie, Li, Xiaoye, Chen, Zhangzhang, Xu, Qing, Li, Xiaoyu, Lv, Qianzhou
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7417776/ https://www.ncbi.nlm.nih.gov/pubmed/32780229 http://dx.doi.org/10.1007/s00228-020-02962-5

Ejemplares similares

Vancomycin Associated Acute Kidney Injury: A Longitudinal Study in China
por: Kunming, Pan, et al.
Publicado: (2021)

Vancomycin associated acute kidney injury in patients with infectious endocarditis: a large retrospective cohort study
por: Kunming, Pan, et al.
Publicado: (2023)

Do fluoroquinolones increase aortic aneurysm or dissection incidence and mortality? A systematic review and meta-analysis
por: Chen, Can, et al.
Publicado: (2022)

Soluble interleukin-2 receptor combined with interleukin-8 is a powerful predictor of future adverse cardiovascular events in patients with acute myocardial infarction
por: Pan, Kunming, et al.
Publicado: (2023)

Evaluation of Remote Pharmacist-Led Outpatient Service for Geriatric Patients on Rivaroxaban for Nonvalvular Atrial Fibrillation During the COVID-19 Pandemic
por: Li, Xiaoye, et al.
Publicado: (2020)

Impact of Renal Function on Effectiveness and Safety Associated With Low Dose Dabigatran in Non-valve Atrial Fibrillation Patients After Catheter Ablation
por: Li, Xiaoye, et al.
Publicado: (2021)

Low Dose Rivaroxaban for Atherosclerotic Cardiovascular Diseases: A Systematic Review and Meta-analysis
por: Chen, Can, et al.
Publicado: (2021)

Hydroxychloroquine safety: A meta-analysis of randomized controlled trials
por: Eljaaly, Khalid, et al.
Publicado: (2020)

Platelet Function and Risk of Bleeding in Patients With Acute Coronary Syndrome Following Tirofiban Infusion
por: Li, Xiaoye, et al.
Publicado: (2019)

Evaluation of pharmacist-led telemedicine medication management for hypertension established patients during COVID-19 pandemic: A pilot study
por: Li, Xiaoye, et al.
Publicado: (2022)

Efficacy and safety of hydroxychloroquine in osteoarthritis: a systematic review and meta-analysis of randomized controlled trials
por: Singh, Ambrish, et al.
Publicado: (2022)

Clinical Efficacy and Safety Comparison of Rivaroxaban and Dabigatran for Nonvalvular Atrial Fibrillation Patients Undergoing Percutaneous Left Atrial Appendage Closure Operation
por: Li, Xiaoye, et al.
Publicado: (2021)

The efficacy and safety of hydroxychloroquine for COVID-19 prophylaxis: A systematic review and meta-analysis of randomized trials
por: Lewis, Kimberley, et al.
Publicado: (2021)

Interaction of Lipids, Mean Platelet Volume, and the Severity of Coronary Artery Disease Among Chinese Adults: A Mediation Analysis
por: Yao, Yao, et al.
Publicado: (2022)

Evaluation of the efficacy and safety of hydroxychloroquine in comparison with chloroquine in moderate and severe patients with COVID-19
por: Li, Qiuyu, et al.
Publicado: (2021)

Assessment of Chloroquine and Hydroxychloroquine Safety Profiles: A Systematic Review and Meta-Analysis
por: Ren, Lu, et al.
Publicado: (2020)

Safety and Efficacy of Hydroxychloroquine in COVID-19: A Systematic Review and Meta-Analysis
por: Ullah, Waqas, et al.
Publicado: (2020)

Efficacy of hydroxychloroquine in hand osteoarthritis: A protocol for systematic review and meta-analysis of randomized clinical trial
por: Li, Qiang-Qiang, et al.
Publicado: (2020)

A case report of drug-induced liver injury after tigecycline administration: histopathological evidence and a probable causality grading as assessed by the updated RUCAM diagnostic scale
por: Shi, Xiaoping, et al.
Publicado: (2022)

Body Mass Index Influence on the Clinical Outcomes for Nonvalvular Atrial Fibrillation Patients Admitted to a Hospital Treated with Direct Oral Anticoagulants: A Retrospective Cohort Study
por: Li, Xiaoye, et al.
Publicado: (2021)

Homocysteine Impairs Endothelial Cell Barrier Function and Angiogenic Potential via the Progranulin/EphA2 Pathway
por: Tian, Dan, et al.
Publicado: (2021)

Comparative Effectiveness of Adjuvant Treatment for Resected Hepatocellular Carcinoma: A Systematic Review and Network Meta-Analysis
por: Liu, Ying, et al.
Publicado: (2021)

Systematic review and meta-analysis of the safety of chloroquine and hydroxychloroquine from randomized controlled trials on malarial and non-malarial conditions
por: Souza Botelho, Mayra, et al.
Publicado: (2021)

Systematic review and meta-analysis of efficacy and safety of hydroxychloroquine and chloroquine in the treatment of COVID-19
por: Mittal, Niti, et al.
Publicado: (2021)

The Impact of Dabigatran and Rivaroxaban on Variation of Platelet Activation Biomarkers and DRT Following Percutaneous Left Atrial Appendage Closure
por: Li, Xiaoye, et al.
Publicado: (2021)

Systematic review and meta-analysis of randomized trials of hydroxychloroquine for the prevention of COVID-19
por: García-Albéniz, Xabier, et al.
Publicado: (2022)

Development and Validation of a Novel Tool for the Prediction of Clopidogrel Response in Chinese Acute Coronary Syndrome Patients: The GeneFA Score
por: Wu, Hongyi, et al.
Publicado: (2022)

A Novel Biomarker Scoring System Alone or in Combination with the GRACE Score for the Prognostic Assessment in Non-ST-Elevation Myocardial Infarction
por: Yao, Yao, et al.
Publicado: (2022)

Mortality, viral clearance, and other clinical outcomes of hydroxychloroquine in COVID‐19 patients: A systematic review and meta‐analysis of randomized controlled trials
por: Kashour, Zakariya, et al.
Publicado: (2021)

The efficacy and safety of hydroxychloroquine (HCQ) in treatment of COVID19 –a systematic review and meta-analysis
por: Choudhuri, Anirban Hom, et al.
Publicado: (2021)

Efficacy and Safety of Hydroxychloroquine for Hospitalized COVID-19 Patients: A Systematic Review and Meta-Analysis
por: Hernandez, Adrian V., et al.
Publicado: (2021)

Is hydroxychloroquine effective in treating primary Sjogren’s syndrome: a systematic review and meta-analysis
por: Wang, Shi-Qin, et al.
Publicado: (2017)

Diagnostic Value of Circulating Progranulin and Its Receptor EphA2 in Predicting the Atheroma Burden in Patients with Coronary Artery Disease
por: Tian, Dan, et al.
Publicado: (2021)

Association between CYP2C9, VORC1, VDR, and APOE genotypes on warfarin maintenance and response during initial anticoagulation for Chinese patients with heart valve replacement
por: Li, Xiaoye, et al.
Publicado: (2022)

Follow-Up Factors Contribute to Immunosuppressant Adherence in Kidney Transplant Recipients
por: Chen, Tingting, et al.
Publicado: (2022)

Efficacy and safety of hydroxychloroquine for managing glycemia in type-2 diabetes: A systematic review and meta-analysis
por: Dutta, D, et al.
Publicado: (2022)

Safety of hydroxychloroquine for treatment or prevention of SARS‐CoV‐2 infection: A rapid systematic review and meta‐analysis of randomized clinical trials
por: Maraolo, Alberto Enrico, et al.
Publicado: (2020)

Real-World Data of Tigecycline-Associated Drug-Induced Liver Injury Among Patients in China: A 3-year Retrospective Study as Assessed by the Updated RUCAM
por: Shi, Xiaoping, et al.
Publicado: (2021)

No benefit of hydroxychloroquine in COVID-19: Results of Systematic Review and Meta-Analysis of Randomized Controlled Trials”()
por: Pathak, Dr Subodh Kumar, et al.
Publicado: (2020)

Hydroxychloroquine for treatment of COVID-19 patients: a systematic review and meta-analysis of randomized controlled trials
por: de Moraes, Vinícius Ynoe, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_e9g93kojo5re562131tp7mt5is